Phenominer Database Results (48 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
WKY/N mean arterial blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait male 84.0 days 15 110.0 mmHg 8.0 30.98 vascular fluid filled catheter right carotid 13061 327
WKY/N heart wet weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart mass male 84.0 days 15 1.2 g 0.05 0.21 post excision weight measurement 13063 327
WKY/N heart left ventricle wet weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart left ventricle mass male 84.0 days 15 0.79 g 0.04 0.17 post excision weight measurement 13064 327
WKY/N mean arterial blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait female 84.0 days 22 117.0 mmHg 5.0 23.45 vascular fluid filled catheter right carotid 13069 327
WKY/N heart weight to body weight ratio control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart mass female 84.0 days 22 2.55 g/kg 0.24 1.13 post excision weight measurement 13073 327
WKY/N both kidneys wet weight to body weight ratio control condition (between 42 and 77 days) Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney mass male 126.0 days-182.0 days 6.1 g/kg 0.4 post excision weight measurement kidney 0.0 107533 3090
WKY/N kidney total tubule cast count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney integrity trait male 126.0 days-182.0 days 1.0 /section 1.0 ex vivo light microscopy with histochemistry 0.0 107553 3090
WKY/N renal fibrosis foci count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney integrity trait male 126.0 days-182.0 days 5.9 /section 0.7 ex vivo light microscopy with histochemistry 0.0 107557 3090
WKY/N heart left ventricle weight to body weight ratio control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart left ventricle mass female 84.0 days 22 1.68 mg/g 0.14 0.66 post excision weight measurement 13074 327
WKY/N heart left ventricle wet weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart left ventricle mass female 84.0 days 22 0.59 g 0.05 0.24 post excision weight measurement 13072 327
WKY/N blood glucose level glucose solution (2 g/kg) Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 blood glucose amount both 118.0 days-125.0 days 220 406.8 mg/dl 4.67 69.3 intraperitoneal glucose tolerance test 0 glucose injection 30 min 65976 114
WKY/N both adrenal glands weight to body weight ratio control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 adrenal gland mass both 167.0 days-174.0 days 210 21.6 mg/100g 0.23 3.4 post excision weight measurement 0 65994 114
WKY/N ratio of deaths related to chronic hypertension to total study population during a period of time control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. total life span male 168.0 days-189.0 days 25 0.0 % unspecified method 0.0 ratio of deaths related to chronic hypertension to total study population during a period of time (CMO:0003800) 107516 3090
WKY/N body weight control condition (for 42 days) Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. body mass male 126.0 days-147.0 days 309.0 g 8.0 body weighing method 0.0 107525 3090
WKY/N kidney glomerular lesion count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney glomerulus integrity trait male 126.0 days-182.0 days 0.8 /section 0.5 ex vivo light microscopy with histochemistry renal glomerulus 0.0 107537 3090
WKY/N urine total protein excretion rate control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. urine protein amount male 210.0 days-224.0 days 18.0 mg/d 2.0 urine protein analysis 86400.0 metabolic cage; sulfosalicylic acid method 107471 3088
WKY/N kidney tubule regeneration foci count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney integrity trait male 126.0 days-182.0 days 0.25 /section 0.25 ex vivo light microscopy with histochemistry 0.0 107545 3090
WKY/N kidney tubule regeneration foci count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney integrity trait male 210.0 days-224.0 days 0.5 /section 0.4 ex vivo light microscopy with histochemistry 0.0 foci of tubular regeneration 107483 3088
WKY/N interstitial nephritis foci count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney integrity trait male 210.0 days-224.0 days 0.9 /section 0.4 ex vivo light microscopy with histochemistry 0.0 foci of interstitial nephritis 107487 3088
WKY/N hematocrit control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 erythrocyte quantity both 132.0 days-139.0 days 208 56.3 % 0.31 4.4 automated blood cell counting method 0 65911 114
WKY/N body weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. body mass male 84.0 days 15 399.0 g 16.0 61.97 body weighing method 13062 327
WKY/N heart left ventricle weight to body weight ratio control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart left ventricle mass male 84.0 days 15 1.99 mg/g 0.08 0.31 post excision weight measurement 13066 327
WKY/N diastolic blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait female 84.0 days 22 103.0 mmHg 9.0 42.21 vascular fluid filled catheter right carotid 13068 327
WKY/N systolic blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait female 84.0 days 22 130.0 mmHg 5.0 23.45 vascular fluid filled catheter right carotid 13067 327
WKY/N body weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. body mass female 84.0 days 22 353.0 g 19.0 89.12 body weighing method 13070 327
WKY/N both adrenal glands wet weight control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 adrenal gland mass both 167.0 days-174.0 days 210 45.7 mg 0.32 4.6 post excision weight measurement 0 65988 114
WKY/N systolic blood pressure control condition Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. arterial blood pressure trait both 180.0 days-270.0 days 9 109.0 mmHg 7.0 21.0 tail cuff plethysmography 0.0 107636 3094
WKY/N net sodium influx to blood lymphocyte dry weight ratio per unit time control condition Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. sodium ion homeostasis trait both 180.0 days-270.0 days 11 5.12 mmol/kg/h 2.6 8.62 flame photometry 0.0 107640 3094
WKY/N interstitial nephritis foci count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney integrity trait male 126.0 days-182.0 days 0.5 /section 0.3 ex vivo light microscopy with histochemistry 0.0 107549 3090
WKY/N renal fibrosis foci count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney integrity trait male 210.0 days-224.0 days 16.0 /section 1.0 ex vivo light microscopy with histochemistry 0.0 foci of renal fibrosis 107495 3088
WKY/N blood hemoglobin level control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 blood hemoglobin amount both 132.0 days-139.0 days 208 16.1 g/dl 0.08 1.2 automated blood cell counting method 0 65917 114
WKY/N platelet count control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 platelet quantity both 132.0 days-139.0 days 208 741.0 x 1000 /ul 4.16 60.0 automated blood cell counting method 0 65929 114
WKY/N red blood cell count control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 erythrocyte quantity both 132.0 days-139.0 days 208 8.89 x 10E6 cells/ul 0.04 0.64 automated blood cell counting method 0 65935 114
WKY/N white blood cell count control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 leukocyte quantity both 132.0 days-139.0 days 208 4.7 x 1000 cells/ul 0.06 0.8 automated total white blood cell count test 0 65941 114
WKY/N systolic blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait male 84.0 days 15 129.0 mmHg 8.0 30.98 vascular fluid filled catheter right carotid 13059 327
WKY/N diastolic blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait male 84.0 days 15 91.0 mmHg 8.0 30.98 vascular fluid filled catheter right carotid 13060 327
WKY/N heart weight to body weight ratio control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart mass male 84.0 days 15 2.99 g/kg 0.08 0.31 post excision weight measurement 13065 327
WKY/N blood glucose level glucose solution (2 g/kg) Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 blood glucose amount both 118.0 days-125.0 days 220 221.4 mg/dl 3.37 50.04 intraperitoneal glucose tolerance test 0 glucose injection 120 min 65982 114
WKY/N heart weight to body weight ratio control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 heart mass both 167.0 days-174.0 days 45 3.96 g/kg 0.04 0.25 post excision weight measurement 0 66000 114
WKY/N net potassium efflux to blood lymphocyte dry weight ratio per unit time control condition Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. potassium ion homeostasis trait both 180.0 days-270.0 days 9 7.38 mmol/kg/h 2.3 6.9 flame photometry 0.0 107642 3094
WKY/N mean corpuscular volume control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 erythrocyte size trait both 132.0 days-139.0 days 208 63.3 fl 0.06 0.8 automated blood cell counting method 0 65923 114
WKY/N blood glucose level glucose solution (2 g/kg) Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 blood glucose amount both 118.0 days-125.0 days 220 138.24 mg/dl 0.79 11.7 intraperitoneal glucose tolerance test 0 glucose injection min 65946 114
WKY/N heart wet weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart mass female 84.0 days 22 0.9 g 0.07 0.33 post excision weight measurement 13071 327
WKY/N systolic blood pressure control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 arterial blood pressure trait both 125.0 days-132.0 days 220 143.0 mmHg 0.74 11.0 tail cuff piezoplethysmography 6-8 readings per sitting 11672 114
WKY/N body weight control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 body mass both 70.0 days 220 215.0 g 1.36 20.1 body weighing method 0 66008 114
WKY/N kidney weight control condition (between 42 and 77 days) Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney mass male 126.0 days-182.0 days 2.18 g 0.08 post excision weight measurement kidney 0.0 107529 3090
WKY/N kidney glomerular lesion count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney glomerulus integrity trait male 210.0 days-224.0 days 0.5 /section 0.4 ex vivo light microscopy with histochemistry 0.0 107475 3088
WKY/N kidney total tubule cast count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney integrity trait male 210.0 days-224.0 days 0.6 /section 0.3 ex vivo light microscopy with histochemistry 0.0 total tubular casts 107491 3088